Thursday, April 29, 2021
3–8:30 p.m. EDT
Organizers:
Eugenia Girda, MD, FACOG – Rutgers Cancer Institute of New Jersey
Eric A. Singer, MD, MA, MS, FACS – Rutgers Cancer Institute of New Jersey
Kristen R. Spencer, MPH, DO – Rutgers Cancer Institute of New Jersey
ACI New Brunswick Program Registration
You must be registered to attend the program.
Program Agenda
April 29, 2021, Program
The program is hosted through Zoom Webinar.
|
2:45–3 p.m.
|
Welcome, Introduction, SITC Resources
|
|
Session I: Cancer Immunotherapy
|
|
3–3:30 p.m.
|
Immunotherapy for the Treatment of Skin Cancers
|
|
3:30–4 p.m.
|
Immunotherapy for the Treatment of Lung Cancer
|
|
4–4:30 p.m.
|
Immunotherapy for the Treatment of Hematologic Malignancies
|
| 4:30–5 p.m. |
Immunotherapy for the Treatment of Genitourinary Malignancies
|
| 5–5:15 p.m. |
Break
|
| 5:15–5:45 p.m. |
Immunotherapy for the Treatment of Head and Neck Cancers
|
| 5:45–6:15 p.m. |
Immunotherapy for the Treatment of Additional Solid Tumors
|
| Session II: Immunotherapy Challenges and Beyond |
| 6:15–6:40 p.m. |
Practical Barriers in Cancer Immunotherapy Treatment |
| 6:40–6:55 p.m. |
Break |
| 6:55 –7:40 p.m. |
Toxicity Management
|
| 7:40–8:05 p.m. |
What's Next for Cancer Immunotherapy
|
| 8:05–8:25 p.m. |
COVID-19 in Cancer Immunotherapy |
8:25–8:30 p.m.
|
Closing Remarks |